Biogen’s Spinraza zooms through blockbusterland, but analysts are fixated on Alzheimer’s data 글 내용 전체보기
Biogen Revenue Grows 9% in 2Q, Plans to Push Ahead with Alzheimer’s and Acquired New Assets 글 내용 전체보기
Pharma a Significant Driver for Eli Lilly’s 2Q, Company Plans IPO for Animal Health Business 글 내용 전체보기